Stay updated on Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check8 days agoChange DetectedA general NIH banner announces a transition in NIH website content and says that “Super Intelligence” may appear in place of “Artificial Intelligence.” It appears above the unavailable study record.SummaryDifference1%

- Check15 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check22 days agoChange DetectedThe site footer revision advances from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the previous detailed study content. The page displays an access-denied screen, indicating a site-access issue rather than a data update.SummaryDifference19%

- Check64 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6. This is a minor version bump and does not change study content, eligibility, or results.SummaryDifference0.1%

Stay in the know with updates to Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib & Toripalimab in Advanced Solid Tumors Clinical Trial page.